Compounds > gliclazide
Page last updated: 2024-10-27

gliclazide and Active Hyperemia

gliclazide has been researched along with Active Hyperemia in 2 studies

Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

Research Excerpts

ExcerptRelevanceReference
" After dosing glibenclamide induced a significant (P = 0."2.71Forearm vascular reactivity is differentially influenced by gliclazide and glibenclamide in chronically treated type 2 diabetic patients. ( Boes, U; Wascher, TC, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farouque, HM1
Meredith, IT1
Wascher, TC1
Boes, U1

Trials

1 trial available for gliclazide and Active Hyperemia

ArticleYear
Forearm vascular reactivity is differentially influenced by gliclazide and glibenclamide in chronically treated type 2 diabetic patients.
    Clinical physiology and functional imaging, 2005, Volume: 25, Issue:1

    Topics: Adult; Analysis of Variance; Cross-Over Studies; Diabetes Mellitus, Type 2; Dose-Response Relationsh

2005

Other Studies

1 other study available for gliclazide and Active Hyperemia

ArticleYear
Effects of inhibition of ATP-sensitive potassium channels on metabolic vasodilation in the human forearm.
    Clinical science (London, England : 1979), 2003, Volume: 104, Issue:1

    Topics: Adenosine Triphosphate; Adult; Dose-Response Relationship, Drug; Female; Forearm; Gliclazide; Glybur

2003